Pure H2O Bio Technologies (CE) (USOTC:PRHB)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more Pure H2O Bio Technologies (CE) Charts. Click Here for more Pure H2O Bio Technologies (CE) Charts.](/p.php?pid=staticchart&s=NO%5EPRHB&p=8&t=15)
Pure H2O Bio-Technologies, Inc. (Pink Sheets:PRHB) has developed a
unique approach to drinking water treatment, which addresses metal,
pesticide, toxic chemical and pathogenic microbe water contamination.
Using a team of experts on pathogenic microorganisms, toxic chemicals,
and water purification engineering, the system is in the last stages of
development. It uses a disinfectant that kills those microorganisms that
can breach state-of-the-art municipal water treatment and then removes
heavy metals, pesticides, other contaminating substances, and the
disinfectant (SilverTTO™) to yield pure water
that is safe enough for even the most sensitive individuals. This
treatment is designed to protect even those individuals with weak immune
systems, those requiring metal-free water for kidney dialysis, and
especially unable to fight infections from threat organisms such as Cryptosporidium
or E. coli.
All of this development has been made possible because of the experience
and expertise of the company's management team, supported by a
top-flight testing laboratory whose expertise includes in-depth
experience with pathogenic microorganisms that are emerging threats to
safe drinking water.
The team director, Dr. Cecil Felkner is a microbiologist, biochemist and
toxicologist with considerable knowledge and hands-on experience with
water treatment and monitoring solutions to problems in addition to
development of patents (approved and pending) relevant to the drinking
water industry. He served as principal writer/editor for the US EPA
Office of Water Report to Congress for Drinking Water Treatment
Technologies and was Project Manager/Lead writer for EPA office of
Science & Technology/Health and Ecological Criteria Division for Water
and Wastewater. The latter project included producing documents for
upgrading and developing Criteria Documents on Cryptosporidium
and newly emerging waterborne viruses. For the American Waterworks
Association Research Foundation (AWWARF) he was co-principal
investigator on a project, "Evaluation of a Real-time Online Monitoring
Method for Cryptosporidium", AWWARF, Denver, CO, 2004. This online/rapid
water monitoring system for microbes utilized basic and applied research
that he and a physicist had co-developed. He also was Advisor/Consultant
to the Water environment Research Foundation (WERF, 2006) Exploratory
Team involving those risks attributed to waterborne pathogens and
toxicants.
The laboratory of Clancy Environmental Consultants (CEC) performed the
testing for disinfectant efficacy on organisms including Cryptosporidium
(oocysts), Escherichia coli, Enterococcus faecalis and, Pseudomonas
aeruginosa. The choice of this laboratory was because it has
provided significant support to the US Environmental Protection Agency,
AWWA and various other federal and private entities in the drinking
water industry. The president of CEC was co-author of a major review
article for AWWA entitled "The Evolution of Microbiology in the Drinking
Water Industry", P. Rochelle and J. Clancy, J.AWWA, March, 2006.
Professional Engineers, led by Dennis P. Boudreaux, P.E. and COO and
Joseph P. Doxey, CEO, developed the unique water purification units that
purify water at the point-of-entry (POE) and point-of-use (POU) to
remove the disinfectant, chlorine, lead, organic chemicals, biomass,
chloramines, unpleasant tastes, and odors. In conjunction with
granulated activated carbon filtration, the final product, i.e., pure
and healthy water is released for the consumer. Potential uses include,
but are not limited to water treatment for the home (under the counter),
medical/hospital water, well water, multiple residential complexes, and
some industrial processes requiring ultra-pure water.
Although there are other water purification systems available, which
employ filtration and can remove organics, metals, etc., this system
both kills the waterborne pathogens and removes virtually all water
contaminants so that the only thing the consumer gets is pure and
healthy water.
CEO and President of PRHB, Joseph P. Doxey reported, "We are excited
about the drinking water system that we have been able to develop
because it has the potential to provide an additional layer of health
protection to many individuals who could otherwise be at high risk to
disease and even death."
For more information on about SilverTTO™
please visit the newly updated website for Pure H2O Bio-Technologies,
Inc. at www.pureh2obiotech.com
.
About Pure H2O Technologies:
Pure H20 Bio-Technologies, Inc. is a publicly held company specializing
in the manufacturing, design and sale of its unique residential,
commercial and hospital point-of-use potable water disinfection systems.
These systems are specifically designed to work effectively against
water-borne pathogens and remove heavy metals and objectionable
biomasses.
The foregoing press release contains forward-looking statements that can
be identified by such terminology as "expects," "potential," "suggests,"
"may," "intends," or similar expressions. Such forward-looking
statements involve known and unknown risks, uncertainties, and other
factors that may cause the actual results to be materially different
from any future results, performance or achievements expressed or
implied by such statements. In particular, management's expectations
regarding future research, development, and/or commercial results could
be affected by, among other things, uncertainties relating to the
availability of future financing; unexpected regulatory delays or
government regulation generally; the company's ability to obtain or
maintain patent and other proprietary intellectual property protection;
and completion in general. Forward-looking statements speak only as to
the date they were made. The company does not undertake to update
forward-looking statements to reflect circumstances or events that occur
after the date the forward-looking statements are made.